• Abstracts will be accepted in English only
• All abstracts must not exceed 500 words
• A table or figure will count as 150 words
• The total word count does not include the title, authors’ details or references
• The name of the presenting author must appear first in the list of authors<
• An international panel of reviewers will review all abstracts anonymously
• There is no fee for submitting an abstract
• There is no limit to the number of poster abstracts you may submit
• CINP recommends using the NbN nomenclature for psychotropics

---

Abstract submissions must be structured with the following:

• Background
• Aims & Objectives
• Method<
• Results
• Discussion & Conclusion
• References – Use Harvard style, where each reference is numbered in order of use
• Keywords - Mandatory to include three

• Oral Presentation (A small number of abstracts will be selected as a 15+3 min oral presentations in a symposium on the topic in question. If you are not comfortable providing an oral presentation, please only select poster presentation during submission.)
• Poster Presentation (abstracts not selected for oral presentation will be provided a poster presentation)

The CINP International Scientific Programme Committee welcomes abstracts that link the latest, and ground-breaking, preclinical developments with the clinical research on a given topic. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. Please find below the list of topics:

---

Research

• Clinical
• Preclinical
• Translational
• Others

---

By Disorder

• Addiction Disorders
• Attention Deficit Disorders
• Bipolar Disorders
• Childhood & Adolescent Disorders
• COVID-19
• Dementia
• Depression
• Eating Disorders
• Epilepsy
• Obsessive-Compulsive Disorders
• Pain
• Panic Disorders
• Personality Disorders
• Post-Traumatic Stress Disorders
• Premenstrual Dysphoric Disorder
• chizophrenia
• Sexual Disorders
• Sleep Disorders
• Suicide
• Others

---

By Drug & Methodology

• Animal Models
• Anxiolytics
• Brain Stimulation
• Computational Neuroscience
• Drugs for Depression
• Drugs for Insomnia
• Drugs for Psychosis
• Ethics of Psychopharmacology
• Genetics
• History of Psychopharmacology
• Imaging
• Molecular Neurobiology/Pharmacology
• Drugs for Bipolar Disorders
• Neuropathology/Post-Mortem Studies
• Neurophysiology
• Oriental Medicine
• Pharmacoeconomics
• Pharmacogenetics/Kinetics
• Psychoneuroimmunology
• Transcultural Psychopharmacology
• Others